CBUS
Cibus, Inc.
$1.23
-4.65%
$93.9M
No data for this timeframe.
Vol
Market Cap$93.9M
Cap SizeMicro Cap
Analyst ConsensusStrong Buy (78%)
Inst. Holders6 funds
Inst. Value$15.2M
Inst. Activity3 buys / 0 sells
Insider Activity0B / 1S
Insider Net $-$5.94
SEC Reports5
Press Releases5
Recent Activity
Jun 9, 2026
SEC
Cibus appointed board member Craig Wichner as CEO, succeeding interim CEO Peter Beetham who returns to his role as Presi
8-K — Impact 4/10
Jun 8, 2026
Press
Cibus announced a CEO transition: board member Craig Wichner appointed CEO, replacing interim CEO Peter Beetham who retu
Impact 3/10
Jun 8, 2026
leadership
Cibus Names Agricultural Biotechnology Leader Craig Wichner as Chief Executive Officer to Accelerate Growth and Value Creation
<p align="justify">SAN DIEGO, June 08, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “C
Jun 2, 2026
Insider
Finn Mark Terrence sold 77,586 shares
Director @ $0.00 ($0.00)
Jun 2, 2026
Insider
Moretti August J sold 77,586 shares
Director @ $0.00 ($0.00)
Jun 2, 2026
Insider
RIGGS RORY B sold 77,586 shares
Director @ $0.00 ($0.00)
May 26, 2026
SEC
Cibus, Inc.'s shelf registration statement (File No. 333-295954) was declared effective on May 22, 2026. This allows the
EFFECT — Impact 6/10
May 14, 2026
SEC
Cibus reported Q1 2026 revenue of $1.68M (up 63% YoY from $1.03M) and a net loss of $21.2M ($-0.33/share), compared to a
8-K — Impact 5/10
Price Targets
$14.67
+1092.4% upside
Strong Buy
Current $1.23
Low $3.00
Median $16.00
High $25.00
3 analysts
$3.00
$25.00
Analyst Ratings
2Strong Buy
5Buy
2Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Mar 25, 2026 | Jefferies | MAINTAIN | Hold → Hold |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $-0.19 ▼ -58.3% | $-0.26 — $-0.12 | 69% YoY | 2 |
| Next Q | $-0.17 ▼ -37.5% | $-0.24 — $-0.09 | 63% YoY | 2 |
| Current FY | $-0.72 ▼ -61.1% | $-1.05 — $-0.40 | 66% YoY | 2 |
| Next FY | $-0.63 ▼ -215.0% | $-1.06 — $-0.20 | 13% YoY | 2 |
Latest Reports
NEUTRAL
8-K
4/10
Cibus appointed board member Craig Wichner as CEO, succeeding interim CEO Peter Beetham who returns to his role as Presi
Jun 9, 2026
NEUTRAL
Press
3/10
Cibus announced a CEO transition: board member Craig Wichner appointed CEO, replacing interim CEO Peter Beetham who retu
Jun 8, 2026
BEARISH
EFFECT
6/10
Cibus, Inc.'s shelf registration statement (File No. 333-295954) was declared effective on May 22, 2026. This allows the
May 26, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| FMR LLC | $12.7M | ADD |
| VANGUARD GROUP INC | $2.2M | ADD |
| RENAISSANCE TECHNOLOGIES LLC | $120.8K | ADD |
| TWO SIGMA INVESTMENTS, LP | $76.0K | NEW |
| MORGAN STANLEY | $38.5K | TRIM |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Jun 2, 2026 | Finn Mark | A | $0.00 |
| Jun 2, 2026 | Moretti August | A | $0.00 |
| Jun 2, 2026 | RIGGS RORY | A | $0.00 |
| Jun 2, 2026 | Urban Thomas | A | $0.00 |
| Jun 2, 2026 | Wichner Craig | A | $0.00 |
6 institutional holders with $15.2M total value (8,711,256 shares) as of 2025-Q4. Top holders: FMR, VANGUARD, RENAISSANCE. Net buying activity: 3 institutions added/increased vs 0 reduced.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | FMR LLC | 7,319,174 | $12.7M | 84.0% | ADD +55.7% |
| 2 | VANGUARD GROUP INC | 1,239,364 | $2.2M | 14.2% | ADD +28.8% |
| 3 | RENAISSANCE TECHNOLOGIES LLC | 69,400 | $120.8K | 0.8% | ADD +74.4% |
| 4 | TWO SIGMA INVESTMENTS, LP | 43,667 | $76.0K | 0.5% | NEW |
| 5 | MORGAN STANLEY | 22,123 | $38.5K | 0.3% | TRIM -65.8% |
| 6 | BANK OF AMERICA CORP /DE/ | 17,528 | $30.5K | 0.2% | ADD +26.6% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | ADD | 962,370 | 1,239,364 | +28.8% | $2.2M | 2025-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | ADD | 39,800 | 69,400 | +74.4% | $120.8K | 2025-Q4 |
| TWO SIGMA INVESTMENTS, LP | NEW | — | 43,667 | — | $76.0K | 2025-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | NEW | — | 39,800 | — | $51.3K | 2025-Q3 |
| MORGAN STANLEY | TRIM | 67,809 | 23,217 | -65.8% | $29.9K | 2025-Q3 |
| BANK OF AMERICA CORP /DE/ | ADD | 14,365 | 18,183 | +26.6% | $23.5K | 2025-Q3 |
| UBS Group AG | NEAR_EXIT | 132,194 | 12,837 | -90.3% | $16.6K | 2025-Q3 |
| TWO SIGMA INVESTMENTS, LP | EXIT | 18,163 | 0 | -100.0% | $0.00 | 2025-Q3 |
| FMR LLC | ADD | 4,615,444 | 7,188,005 | +55.7% | $9.9M | 2025-Q2 |
| UBS Group AG | DOUBLED | 20,194 | 132,194 | +554.6% | $182.4K | 2025-Q2 |
| MORGAN STANLEY | TRIM | 104,115 | 67,809 | -34.9% | $93.6K | 2025-Q2 |
| BANK OF AMERICA CORP /DE/ | TRIM | 25,576 | 14,365 | -43.8% | $19.8K | 2025-Q2 |
| WELLS FARGO & COMPANY/MN | NEAR_EXIT | 10,924 | 311 | -97.2% | $429.00 | 2025-Q2 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | EXIT | 55,142 | 0 | -100.0% | $0.00 | 2025-Q2 |
| RENAISSANCE TECHNOLOGIES LLC | EXIT | 22,484 | 0 | -100.0% | $0.00 | 2025-Q2 |
| MORGAN STANLEY | ADD | 78,048 | 104,115 | +33.4% | $194.7K | 2025-Q1 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | ADD | 41,559 | 55,142 | +32.7% | $103.1K | 2025-Q1 |
| RENAISSANCE TECHNOLOGIES LLC | NEAR_EXIT | 127,100 | 22,484 | -82.3% | $42.0K | 2025-Q1 |
| UBS Group AG | TRIM | 39,821 | 20,194 | -49.3% | $37.8K | 2025-Q1 |
| TWO SIGMA INVESTMENTS, LP | TRIM | 24,574 | 15,551 | -36.7% | $29.1K | 2025-Q1 |
| RENAISSANCE TECHNOLOGIES LLC | DOUBLED | 12,300 | 127,100 | +933.3% | $353.3K | 2024-Q4 |
| MORGAN STANLEY | ADD | 51,982 | 78,048 | +50.1% | $217.0K | 2024-Q4 |
| UBS Group AG | DOUBLED | 15,465 | 39,821 | +157.5% | $110.7K | 2024-Q4 |
| WELLS FARGO & COMPANY/MN | ADD | 8,338 | 10,683 | +28.1% | $29.7K | 2024-Q4 |
| MORGAN STANLEY | DOUBLED | 20,192 | 51,982 | +157.4% | $169.5K | 2024-Q3 |
13 unique insiders with 1 transactions. Net insider value: -$5.94 ($0.00 bought, $5.94 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 2, 2026 | Finn Mark Terrence | Director | A | 77,586 | $0.00 | $0.00 |
| Jun 2, 2026 | Moretti August J | Director | A | 77,586 | $0.00 | $0.00 |
| Jun 2, 2026 | RIGGS RORY B | Director | A | 77,586 | $0.00 | $0.00 |
| Jun 2, 2026 | Urban Thomas | Director | A | 64,748 | $0.00 | $0.00 |
| Jun 2, 2026 | Wichner Craig | Director | A | 77,586 | $0.00 | $0.00 |
| Jun 2, 2026 | Box Kimberly Ann | Director | A | 77,586 | $0.00 | $0.00 |
| Jun 2, 2026 | Lehmann Jean-Pierre Jules | Director | A | 64,748 | $0.00 | $0.00 |
| Jun 2, 2026 | Prante Gerhard | Director | A | 64,748 | $0.00 | $0.00 |
| Apr 24, 2026 | Beetham Peter | Interim CEO, Pres & COO | A | 195,000 | $0.00 | $0.00 |
| Apr 24, 2026 | Broos Carlo | CFO | A | 57,000 | $0.00 | $0.00 |
| Apr 24, 2026 | Beetham Peter | Interim CEO, Pres & COO | A | 390,000 | $0.00 | $0.00 |
| Apr 24, 2026 | Broos Carlo | CFO | A | 57,000 | $0.00 | $0.00 |
| Apr 24, 2026 | Urban Thomas | Director | A | 9,094 | $0.00 | $0.00 |
| Apr 24, 2026 | Gocal Gregory Francis William | Chief Scientific Officer & EVP | A | 57,000 | $0.00 | $0.00 |
| Apr 24, 2026 | Gocal Gregory Francis William | Chief Scientific Officer & EVP | A | 114,000 | $0.00 | $0.00 |
| Apr 24, 2026 | Broos Carlo | CFO | A | 114,000 | $0.00 | $0.00 |
| Apr 24, 2026 | Stokes Jason | CAO, Gen Csl & Corp Secy | A | 57,000 | $0.00 | $0.00 |
| Apr 24, 2026 | Stokes Jason | CAO, Gen Csl & Corp Secy | A | 114,000 | $0.00 | $0.00 |
| Apr 24, 2026 | Sauer Noel | Sr VP, Research | A | 38,000 | $0.00 | $0.00 |
| Apr 24, 2026 | Sauer Noel | Sr VP, Research | A | 76,000 | $0.00 | $0.00 |
| Apr 24, 2026 | Broos Carlo | CFO | A | 114,000 | $0.00 | $0.00 |
| Mar 30, 2026 | Broos Carlo | CFO | F | 3,676 | $1.87 | $6.9K |
| Mar 30, 2026 | Stokes Jason | CLO, Gen Csl & Secy | F | 3,695 | $1.83 | $6.8K |
| Mar 30, 2026 | Sauer Noel | Sr VP, Research | F | 1,763 | $1.84 | $3.2K |
| Mar 30, 2026 | Beetham Peter | Interim CEO, Pres & COO | F | 16,112 | $1.85 | $29.8K |
| Mar 30, 2026 | Gocal Gregory Francis William | Chief Scientific Officer & EVP | F | 8,954 | $1.82 | $16.3K |
| Feb 19, 2026 | Stokes Jason | CLO, Gen Csl & Secy | F | 4,795 | $2.98 | $14.3K |
| Jan 29, 2026 | RIGGS RORY B | Director | A | 333,333 | $1.50 | $500.0K |
| Jan 29, 2026 | Lehmann Jean-Pierre Jules | Director | A | 666,666 | $1.50 | $1000.0K |
| Nov 11, 2025 | Stokes Jason | CLO, Gen Csl & Secy | F | 3,519 | $1.32 | $4.6K |
| Nov 11, 2025 | Broos Carlo | CFO | F | 1,496 | $1.32 | $2.0K |
| Nov 11, 2025 | Sauer Noel | Sr VP, Research | F | 1,834 | $1.32 | $2.4K |
| Jun 13, 2025 | Sauer Noel | Sr VP, Research | SELL | 4 | $1.49 | $5.94 |
| Feb 19, 2025 | Stokes Jason | CLO, Gen Csl & Secy | F | 4,795 | $2.33 | $11.1K |
5 SEC filing reports analyzed. Sentiment: 0 bullish, 2 bearish, 0 mixed, 3 neutral. Avg impact: 5.0/10.
NEUTRAL
8-K
4/10
Cibus appointed board member Craig Wichner as CEO, succeeding interim CEO Peter Beetham who returns
Jun 9, 2026
BEARISH
EFFECT
6/10
Cibus, Inc.'s shelf registration statement (File No. 333-295954) was declared effective on May 22, 2
May 26, 2026
NEUTRAL
8-K
5/10
Cibus reported Q1 2026 revenue of $1.68M (up 63% YoY from $1.03M) and a net loss of $21.2M ($-0.33/s
May 14, 2026
NEUTRAL
DEFA14A
3/10
Cibus, Inc. is holding its 2026 annual meeting to elect nine directors, approve executive compensati
Apr 20, 2026
BEARISH
424B5
7/10
Cibus, Inc. (CBUS) is conducting a public offering of 6,976,744 shares of Class A common stock at $2
Mar 26, 2026
NEUTRAL
3/10
Cibus announced a CEO transition: board member Craig Wichner appointed CEO, replacing interim CEO Pe
Jun 8, 2026
NEUTRAL
2/10
Cibus announced transfer of gene-edited herbicide-tolerant rice materials to partner Interoc for tes
May 4, 2026
NEUTRAL
5/10
Cibus US LLC (CBUS) announced the pricing of a public offering of 6,976,744 shares at $2.15 per shar
Mar 26, 2026
NEUTRAL
5/10
Cibus US LLC (CBUS) announced plans for an underwritten public offering of its Class A common stock
Mar 25, 2026
BEARISH
6/10
Cibus reported Q4 2025 financial results with declining revenue and a wider net loss, driven by a $9
Mar 17, 2026
Current analyst consensus: Buy (78% buy). Based on 9 analysts: 2 strong buy, 5 buy, 2 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$14.67 mean target
+1092.4% upside
Strong Buy (3.00)
$3.00 Low
$25.00 High
| Metric | Value |
|---|---|
| Current Price | $1.23 |
| Target Low | $3.00 |
| Target Mean | $14.67 |
| Target Median | $16.00 |
| Target High | $25.00 |
| # Analysts | 3 |
| Recommendation | Strong Buy (3.00) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$-0.19 | $-0.26 | $-0.12 | 68.8% | -58.3% | 1↑ 0↓ | $0.0B | 87.8% | 2 |
| Next Q 2026-09-30 |
$-0.17 | $-0.24 | $-0.09 | 62.5% | -37.5% | 1↑ 0↓ | $0.0B | 229.5% | 2 |
| Current FY 2026-12-31 |
$-0.72 | $-1.05 | $-0.40 | 65.8% | -61.1% | 1↑ 0↓ | $0.0B | 113.8% | 2 |
| Next FY 2027-12-31 |
$-0.63 | $-1.06 | $-0.20 | 13.1% | -215.0% | 1↑ 0↓ | $0.0B | 77.6% | 2 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-0.190 | |
| 7d ago | $-0.120 | -0.070 |
| 30d ago | $-0.120 | -0.070 |
| 60d ago | $-0.120 | -0.070 |
| 90d ago | $-0.120 | -0.070 |
1 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 0 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Mar 25, 2026 | Jefferies | MAINTAIN | Hold | Hold |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 2 | 5 | 2 | 0 | 0 | 78% | |
| May 1, 2026 | 2 | 5 | 2 | 0 | 0 | 78% | |
| Apr 1, 2026 | 2 | 5 | 2 | 0 | 0 | 78% | |
| Mar 1, 2026 | 2 | 5 | 2 | 0 | 0 | 78% | |
| Feb 1, 2026 | 2 | 5 | 2 | 0 | 0 | 78% | |
| Jan 1, 2026 | 2 | 6 | 2 | 0 | 0 | 80% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
Jun 8, 2026
leadership
Cibus Names Agricultural Biotechnology Leader Craig Wichner as Chief Executive Officer to Accelerate Growth and Value Creation
<p align="justify">SAN DIEGO, June 08, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”), a leading agricultural techno
May 14, 2026
earnings_calendar
CBUS Q1 2026 Earnings Scheduled — 2026-05-14
May 7, 2026
earnings_calendar
CBUS Q1 2026 Earnings Scheduled — 2026-05-07
May 4, 2026
contract
Cibus Announces Transfer of Gene-Edited Herbicide Tolerance Traits in Interoc Rice Seeds for Testing and Production
Represents achievement of strategic milestone for Cibus’ anticipated first commercial offering in the South American market <pre>Represents achievemen
Apr 15, 2026
other
Cibus Announces the Election of Thomas Urban to Board of Directors
<p>SAN DIEGO, April 15, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”), a leading agricultural technology company th
Apr 10, 2026
short_volume
Short Volume: CBUS — 63.0% short (0.5M / 0.9M)
Short: 540,283 | Exempt: 34,173 | TRF Vol: 857,489 | Short Ratio: 63.0% | Off-exchange volume (dark pool + OTC)
Apr 8, 2026
short_volume
Short Volume: CBUS — 66.6% short (0.4M / 0.7M)
Short: 444,868 | Exempt: 41,373 | TRF Vol: 667,812 | Short Ratio: 66.6% | Off-exchange volume (dark pool + OTC)
Mar 30, 2026
short_volume
Short Volume: CBUS — 69.8% short (0.4M / 0.5M)
Short: 352,035 | Exempt: 17,757 | TRF Vol: 504,063 | Short Ratio: 69.8% | Off-exchange volume (dark pool + OTC)
Mar 27, 2026
short_volume
Short Volume: CBUS — 79.5% short (0.8M / 1.0M)
Short: 770,863 | Exempt: 57,083 | TRF Vol: 969,498 | Short Ratio: 79.5% | Off-exchange volume (dark pool + OTC)
Mar 26, 2026
offering
Cibus, Inc. Announces Pricing of Public Offering of Class A Common Stock
<p align="justify">SAN DIEGO, March 26, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”), a leading agricultural techn
Mar 25, 2026
offering
Cibus, Inc. Announces Proposed Public Offering of Class A Common Stock and Pre-Funded Warrants
<p align="justify">SAN DIEGO, March 25, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”), a leading agricultural techn
Mar 17, 2026
earnings
Cibus Reports Fourth Quarter Financial Results and Provides Business Update
<p align="justify">SAN DIEGO, March 17, 2026 (GLOBE NEWSWIRE) -- <strong>Cibus, Inc. (Nasdaq: CBUS) (the "Company"), </strong>a leading agricultural
Mar 17, 2026
earnings_calendar
CBUS Q4 2025 Earnings After Market Close — 2026-03-17